Rate My Professor Andre Ng

Professor André Ng is Head of the Department of Cardiovascular Sciences and Professor of Cardiac Electrophysiology at the University of Leicester. He also serves as Consultant Cardiologist and Electrophysiologist at the University Hospitals of Leicester NHS Trust. Ng holds MBChB and PhD degrees, obtained during his training in Glasgow. He joined the University of Leicester as Senior Lecturer in Cardiology in 2002 and was awarded a personal chair in Cardiac Electrophysiology in 2013. His research interests include autonomic modulation of electrical restitution and ventricular fibrillation initiation, the role of nitric oxide in vagal protection against ventricular fibrillation, non-invasive markers for ventricular arrhythmia risk stratification, spectral characteristics and catheter ablation in atrial fibrillation, and electromechanical refinement of multi-site cardiac pacing. Ng leads cross-disciplinary teams investigating cardiac arrhythmia mechanisms, neurocardiac interactions, sudden cardiac death risk prediction, and atrial fibrillation pathophysiology. He has developed LifeMap technology for sudden cardiac death risk stratification, for which he holds two international patents.

Ng's career encompasses extensive leadership roles, including President of the British Cardiovascular Society since 2024, Director of the British Heart Foundation Leicester Centre of Research Excellence, Vice President (Research and Education) and Chair of the Programme Committee for the British Cardiovascular Society, Non-Executive Director of Northampton General Hospital NHS Trust, and positions on committees such as NICE Interventional Procedures Programme, JRCPTB Specialist Advisory Committee in Cardiology, and BHF Project Grants Committee. He pioneered an active atrial fibrillation ablation programme at Glenfield Hospital in 2002, introduced novel robotic systems for atrial fibrillation ablation, and specializes in advanced device implantations including pacemakers, implantable cardioverter defibrillators, and cardiac resynchronisation therapy devices. Key publications include Kirchhof P et al., 'Early Rhythm-Control Therapy in Patients with Atrial Fibrillation' (New England Journal of Medicine, 2020); Ng GA et al., 'LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use' (Europace, 2018); and Li X et al., 'Standardizing Single-Frame Phase Singularity Identification Algorithms and Parameters in Phase Mapping During Human Atrial Fibrillation' (Frontiers in Physiology, 2020). His innovations earned the Medical Futures Award 2011 for Best Innovation in Diagnostics and the European Heart Rhythm Association Inventors Award 2016. Ng is a Fellow of the Royal Colleges of Physicians (Glasgow and London), European Society of Cardiology, European Heart Rhythm Association, and Higher Education Academy. As national chief investigator and principal investigator for clinical trials, he has advanced cardiovascular guidelines and patient care.